Purchase 3-MeO-PCP
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 3-MeO-PCP for sale
3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP) which has been sold online as a designer drug. It acts mainly as an NMDA receptor antagonist, though it has also been found to interact with the sigma σ1 receptor and the serotonin transporter.
3-MeO-PCP is an arylcyclohexylamine dissociative. 3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP). It acts mainly as an NMDA receptor antagonist, though it has also been found to interact with the sigma σ1 receptor and the serotonin transporter. The drug does not possess any opioid activity nor act as a dopamine reuptake inhibitor.
3-MeO-PCP is a dissociative drug of the arylcyclohexylamine class. It can be chemically described as 1-(1-(4-methoxyphenyl)cyclohexyl)piperidine and is structurally similar to PCP in the way that it contains an ester in place of a ketone group. 3-MeO-PCP is an analog of PCP, but it is not particularly related to or derived from phencyclidine in any meaningful way.
3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative hallucinogen of the triply aromatic arylcyclohexylamine class related to phencyclidine (PCP).
3-MeO-PCP is a structural analog and functional agonist of PCP, which means that it can be easily ordered from websites that sell the drug without a prescription. This drug acts mainly as an NMDA receptor antagonist, but it has also been found to interact with the sigma σ1 receptor and the serotonin transporter. The drug does not possess any opioid activity nor act as a dopamine reuptake inhibitor.
3-MeO-PCP is a dissociative drug that can be habit-forming. Long-term use can lead to dependence and withdrawal.
3-Methoxy PCP (3-MeO-PCP), also known as methoxetamine and 3-MeO-phencyclidine (3-MeO-PCP), is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP). It was developed in the 1960s but had little psychoactive effects until 2000. 3-MeO-PCP acts mainly as an NMDA receptor antagonist, though it has also been found to interact with the sigma σ1 receptor and the serotonin transporter.
3-Methoxy PCP is a potent NMDA receptor antagonist with little activity on sigma receptors or the serotonin transporter.
3-Methoxy PCP can lead to dangerous psychotic episodes and result in death. Users report experiencing typical dissociative effects such as hallucinations, decreased awareness of the world, and emotional detachment. If you or a loved one is using this drug, please get help.
3-Methoxy PCP has many professional applications for use in science and medicine
3-MeO-PCP is a drug banned in Japan, Sweden, Switzerland, and the United Kingdom.
3-Methoxyphencyclidine (3-MeO-PCP) is a potent dissociative with structural and pharmacological similarities to PCP. Still, with an N-methyl group instead of an N-Boc group at R 1 . This compound has been sold online as a designer drug.
3-MeO-PCP or 3-MeO Phencyclidine is a dissociative drug of the arylcyclohexylamine class. It possesses analgesic, anesthetic, and hallucinogenic effects.
3-MeO-PCP is an arylcyclohexylamine drug. Potent NMDAR antagonist. Has less affinity for the sigma receptor and much less affinity at the serotonin transporter than PCP or ketamine. Binding Search:3-Methoxyphencyclidine
3-MeO-PCP is an arylcyclohexylamine with potent NMDA (N-methyl-D-aspartate) antagonist properties. Compared to PCP and ketamine, 3-MeO-PCP appears to possess less affinity for the sigma receptor and much less affinity at the serotonin transporter.
3-MeO-PCP is a psychoactive substance closely related to other dissociative sedatives such as PCP and ketamine.
3-Methoxy phencyclidine or 3-MeO-PCP is a chemical. The chemical formula of this drug is C12H16ClNO. It is an experimental compound.
3-MeO-PCP is a recreational drug that has an inhibitory effect on the brain's receptors.
3-MeO-PCP is amongst the most potent dissociative drugs like PCP and Ketamine ever created
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $1690
1kg $1690
out of stock
100mg $840
200g $690
500g $1080
1kg $1590
1kg $1890
1kg $1690
1000 pills $45